HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katarzyna Pawlik Selected Research

SB328437

1/2021Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katarzyna Pawlik Research Topics

Disease

12Neuralgia (Stump Neuralgia)
01/2022 - 10/2018
9Hypersensitivity (Allergy)
10/2021 - 10/2018
7Pain (Aches)
01/2022 - 10/2018
3Traumatic Brain Injuries (Traumatic Brain Injury)
12/2020 - 01/2020
3Wounds and Injuries (Trauma)
12/2020 - 01/2020
2Brain Injuries (Brain Injury)
12/2020 - 01/2020
2Chronic Disease (Chronic Diseases)
08/2020 - 01/2020
2Human Influenza (Influenza)
04/2015 - 01/2013
1Infections
10/2021
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
09/2021
1Chronic Renal Insufficiency
09/2021
1Diabetic Neuropathies (Diabetic Neuropathy)
10/2020
1Peripheral Nervous System Diseases (PNS Diseases)
01/2020
1Neuroinflammatory Diseases
01/2020
1Painful Neuropathy
01/2020
1Sepsis (Septicemia)
04/2015
1Gastroenteritis
04/2015
1Cross Infection (Nosocomial Infection)
04/2015
1Rotavirus Infections
04/2015
1Pneumonia (Pneumonitis)
01/2015
1Urinary Tract Infections (Urinary Tract Infection)
04/2008

Drug/Important Bio-Agent (IBA)

8Opioid Analgesics (Opioids)IBA
01/2022 - 10/2018
7Morphine (MS Contin)FDA LinkGeneric
01/2022 - 10/2018
7LigandsIBA
12/2020 - 10/2018
6ChemokinesIBA
12/2020 - 12/2018
5Analgesics (Analgesic Drugs)IBA
10/2021 - 12/2018
4Buprenorphine (Subutex)FDA LinkGeneric
01/2022 - 01/2020
4Proteins (Proteins, Gene)FDA Link
12/2020 - 01/2019
4Messenger RNA (mRNA)IBA
12/2020 - 01/2019
3CytokinesIBA
01/2021 - 01/2019
3Neutralizing AntibodiesIBA
01/2019 - 10/2018
2Chemokine ReceptorsIBA
10/2021 - 12/2020
2Pharmaceutical PreparationsIBA
10/2021 - 04/2008
2CCR ReceptorsIBA
01/2021 - 01/2020
2Complement System Proteins (Complement)IBA
12/2020 - 12/2020
2CC ChemokinesIBA
10/2020 - 08/2020
1Oxycodone (Oxycontin)FDA LinkGeneric
01/2022
1KetamineFDA LinkGeneric
01/2022
1mirogabalinIBA
01/2022
1CXC ChemokinesIBA
10/2021
1Biomarkers (Surrogate Marker)IBA
09/2021
1pro-brain natriuretic peptide (1-76)IBA
09/2021
1HydrazinesIBA
01/2021
1SB328437IBA
01/2021
1LectinsIBA
12/2020
1IntegrinsIBA
12/2020
1Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA
10/2020
1Streptozocin (Streptozotocin)FDA Link
10/2020
1Blood Glucose (Blood Sugar)IBA
10/2020
1Dipyrone (Metamizole)IBA
10/2020
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
01/2020
1InterleukinsIBA
01/2020
1cenicrivirocIBA
01/2020
1UCB 35625IBA
01/2020
1CCR4 ReceptorsIBA
01/2020
1Chemotactic FactorsIBA
01/2019
1SodiumIBA
01/2015
1VaccinesIBA
01/2013

Therapy/Procedure

6Analgesia
01/2022 - 10/2018
3Therapeutics
01/2022 - 01/2020
3Spinal Injections
08/2020 - 12/2018
2Drug Therapy (Chemotherapy)
01/2022 - 10/2020
1Intraperitoneal Injections
10/2020
1Catheters
04/2015
1Vascular Access Devices (Arterial Line)
04/2015